By annette
In this IHE report the author Ulf Persson, senior advisor at IHE, has identified a number of conditions which lead to the fact that today’s methods of valuing medicines hardly lead us to a satisfactory understanding of the value of orphan medicines. The insurance value, the value of hope and process-related benefits are not included. …
By annette
Michael Willis from IHE will participate in two workshops at SMDM-Society for Medical Decision Making, May 21-23 in Berlin. Issue Panel 1C: Proving health economics models are valid – why, how and who? Chair: Talitha Feenstra (National Institute for Public Health and the Environment (RIVM), Netherlands) Panelists: Amanda Adler, University of Oxford, UK Xavier Pouwels, …
By annette
New IHE Report about challenges and opportunities to improve the care of women with triple-negative breast cancer in Asia-Pacific. Read more and download the report
By annette
IHE participates at the conference with a poster presentation on the importance of considering price metrics and market dynamics in US economic evaluation, using the case of SGLT-2 inhibitors in the treatment of T2D. Michael Willis from IHE will also moderate a workshop, “Addressing Heterogeneity in Comparative Economic Analysis in the Decentralized US Setting: Are …
By annette
The Swedish Institute for Health Economics participates at the 11th Asia-Pacific Breast Cancer Summit 2023 on May 4-6, 2023 in Singapore. Thomas Hofmarcher will present findings of an upcoming policy report on triple-negative breast cancer (TNBC) in the Asia-Pacific region. He will highlight the health-economic impact of TNBC on patients and society as well as …
By annette
PRIME-ROSE is a precision cancer medicine trial network and implementation initiative.The PRIME-ROSE vision is access to affordable precision cancer medicine that prolongs life at the best quality possible for all cancer patients. Read more
By annette
We are happy to announce that Dr Michael Willis from IHE is presenting a poster at this year’s annual meeting of the Swedish Health Economic Association (SHEA). The poster presents results from a literature review and assessment of published budget impact models (BIMs) for NSCLC. BIMs are an important basis for decision-making and should be …
By annette
The prevalence of pain has long been focused in haemophilia research but depression and anxiety are less studied. A Nordic collaboration has investigated national prescription drug data in more than 3000 Nordic persons with haemophilia and compared data patterns to population controls. The key study finding is a persistently higher use of pain, depression and …
By annette
Diabetes Two studies focusing on people with type 2 diabetes and established cardiovascular disease (eCVD) in Sweden have been published in the medical journal “Diabetes, Obesity and Metabolism”. The first study examines the burden of hospital-based care, work absence, associated costs and excess mortality in people with type 2 diabetes, with and without eCVD. The …
By annette
New global study on the value of precision medicine in oncology. Read more